Kai Fu is currently a Senior Principal Scientist at Eli Lilly and Company, working on diabetes, obesity, and complications. Previously, Kai contributed as a Scientist at EMD Serono in the Immuno-Oncology and Autoimmune and Inflammatory Diseases departments, and held positions at GSK, Be Biopharma, and Biogen Idec, where they specialized in therapeutic applications and characterizing novel therapeutics. Kai's earlier career included an Associate Scientist role at Abbott Laboratories, focusing on vascular diseases and related ischemic injuries.
This person is not in the org chart
This person is not in any teams
This person is not in any offices